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INTRODUCTION

ABSTRACT
INTRODUCTION: Thyroid crisis is a rare and life-threatening
endocrine emergency characterized by exaggerated clinical
manifestations of hyperthyroidism with cardiovascular
manifestations being the most severe. Rhythm disturbances,
sinus tachycardia and atrial fibrillation, are the commonest
cardiac manifestations of severe thyrotoxicosis; however, asystole
remains a very atypical and uncommon presentation. We present
a case of thyrotoxicosis due to Grave’s disease complicated by
multiple episodes of asystole.
CASE PRESENTATION: A 65-year-old female recently diagnosed
with Grave’s disease presented to the hospital with recurrent
episodes of syncope. Her hospital course was significant for
atrial fibrillation with subsequent progression to sinus pauses
and asystole spontaneously reverting to atrial fibrillation. Her
thyroid hormone levels were found to be markedly elevated
at the time of presentation. She was initially managed with a
temporary pacemaker but ultimately transitioned to a permanent
dual-chamber pacemaker, in addition to concurrent anti-thyroid
treatment with propylthiouracil and prednisone. She made an
uneventful recovery and was discharged from hospital a few days
later with scheduled outpatient follow-up.
CONCLUSION: Asystole due to hyperthyroidism remains a
very uncommon presentation of severe thyrotoxicosis, and
in rarer situations can occur in hyperthyroid patients without
any associated predisposing conditions such as infection,
inflammation or medication use as previously reported. The
mechanisms underlying this rhythm disturbance remain elusive,
nevertheless, its management may require a permanent
pacemaker placement in addition to concurrent medical
treatment of the underlying cause and the thyroid hormone
disturbance using standard hyperthyroid medications.
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hyroid storm, also known as thyroid
crisis, is a rare and life-threatening
endocrine emergency characterized
by exaggerated clinical manifestations of
hyperthyroidism.1 Thyroid storm has a
significant mortality of up to 80% if not
promptly recognized and adequately managed.1–3 The spectrum of cardiovascular
manifestations of thyroid storm can be
diverse, ranging from sinus arrhythmia,
hypertension, to the more fatal severe
congestive heart failure with pulmonary
oedema.4–6 Even though cardiac rhythm
abnormalities such as sinus tachycardia
and atrial fibrillation are common manifestations, cardiac arrest/asystole from
thyroid crisis remains a rare occurrence.
We present a rare case of thyrotoxicosis
due to Grave’s disease complicated by
multiple episodes of asystole.
CASE PRESENTATION
A 65-year-old female with a past medical history of hypertension, heart failure with preserved systolic function,
moderate aortic stenosis, severe pulmonary hypertension, breast cancer, recent
COVID-19 infection, and diagnosis of
hyperthyroidism, presented to the emergency department with symptoms of
lightheadedness, chest discomfort/pain
and multiple episodes of syncope that
started on that day of presentation. Four
weeks prior to her presentation at our facility, she was admitted at another health
facility and was found to have elevated
thyroid hormones levels, low TSH and
positive TSH antibodies consistent with
hyperthyroidism due to Grave’s disease
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Figure 1: Electrocardiograph (ECG) at presentation showing atrial fibrillation

with associated symptoms of significant weight loss
over the prior 3 months. She was placed on propranolol 20 mg three times daily. Methimazole was
not started as part of standard therapy secondary to
concurrent pancytopenia due to an associated viral
illness. She was discharged from the health facility
with normal vital signs and normal sinus rhythm on
electrocardiography. At the time of the current hospital presentation, her vital signs were blood pressure 184/128 mmHg, pulse 119 beats per minute,
temperature 36,7 °C, respiratory rate 25 breaths per
minute and oxygen saturation 98% on room air. She
was noted to be awake and alert but agitated and occasionally confused. She had normal heart sounds,
clear lung fields, non-tender abdomen, and normal
neurologic examination. She was noted to be in atrial fibrillation with rapid ventricular response on the
electrocardiograph (ECG) (Figure 1) with subsequent multiple sinus pauses and then asystole. She
had multiple episodes of asystole lasting between
5 and 10 seconds with spontaneous return to atrial
fibrillation (Figure 2). Her glucose, electrolytes and
renal function tests were normal except for serum
magnesium at 1.5 mmol/L. Her I-stat troponin was
elevated at 0.06 ng/mL with minimal elevation in
her repeat to 0.09 mg/mL after 6 hours, her hemoglobin was 11.1 g/dL, platelet count 111,000 /mm3 and
white cell count at 4600 cells/mm3. Her TSH was
<0.005 (normal: 0.450 - 5.330 uIU/mL), T4 >5.6
© Tower Health
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(normal: 0.58 - 1.64 ng/dL) and T3 at 9.88 (normal:
2.20 - 4.10 pg/mL). Except for the markedly deranged thyroid function tests, her other biochemical
tests results at presentation were grossly unchanged
from those of at discharge from the other health facility, few weeks prior. Chest X ray showed mild
vascular congestion with small right pleural effusion
and her electrocardiogram showed atrial fibrillation
with rapid ventricular response and non-specific ST
and T wave changes. Her electrocardiogram during
her admission to the other facility, 4 weeks to her
presentation to our hospital, showed normal sinus
function. Her overall Burch & Watorsky point scale
score for thyroid crisis likelihood assessment was
50, indicative of a thyroid crisis.
Management included immediate placement of
transcutaneous pacing pads on the patient. Pharmacologic therapy included intravenous magnesium 4
g STAT and intravenous potassium 20 mEq STAT to
replete electrolytes and she was emergently taken to
the cardiac catheterization lab for a temporary pacemaker placement through the right internal jugular
vein during which she had another episode of asystole. The temporary pacemaker placement was successful with a normal sinus rhythm on the rhythm
strip and ECG post-procedure (Figure 3). Later that
evening after further assessment and concerns for
possible deterioration of her arrhythmia with discontinuation of the temporary pacing, a permanent duTransform Med | Vol 1, No 2. June, 2022 | https://doi.org/10.54299/tmed/arqe7136
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Figure 2: R
 hythm strip showing multiple sinus pause episodes, A at 09:01 AM, B at 09:34 AM,
C at 09:46 AM, D at 10:06 AM and E at 10:41 AM. Post pause, the patient reverts to
either atrial fibrillation or sinus rhythm with premature atrial contractions. During the
sinus rhythm, there are no signs of AV node dysfunction such as first or second degree
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Figure 3: Rhythm

strip (A) and Electrocardiograph (B) post temporary
pacemaker showing normal sinus rhythm

A

B

al-chamber pacemaker was inserted. The post-permanent pacemaker insertion rhythm and ECG are
showed on Figure 4. She was started on high dose
prednisone 60 mg daily PO and propylthiouracil
150 mg every 8 hours post procedure. She made an
uneventful recovery in the intensive care unit post
procedure and remained in sinus rhythm and hemodynamically stable. A thyroid ultrasound done later
that day showed a heterogeneous, enlarged, and hyper vascular thyroid with no focal lesion of concern
(The right thyroid lobe measured: 7.3 x 4.2 x 2.8
cm, The left thyroid lobe measured: 7.9 x 4.4 x 2.9
cm, The thickness of the thyroid isthmus measures:
1.0 cm). Her echocardiogram later that day showed
normal left ventricular size and function (ejection
fraction 70%) with no regional wall motion and
grade 2 diastolic dysfunction. There was also mild
right and moderate left atrial enlargement, moderate
mitral regurgitation, moderate aortic stenosis and
severe tricuspid regurgitation with severe pulmonary hypertension. Her propranolol was restarted
© Tower Health
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the following day and she was discharged from the
hospital 3 days after admission. At her follow-up office visit, 1 week after discharge from hospital, her
ECG showed an atrial-paced rhythm at 61 beats per
minute. The pacemaker settings were; mode AAI
DDD, basic rate at 60 beats per minute and upper
tracking and sensor rate at 130 beats per minute. Her
pacemaker device interrogation showed no evidence
of atrial or ventricular arrhythmias. At her follow-up
office visit, 1 month after discharge from hospital,
her pacemaker device interrogation showed a 92%
atrial pacing. There were no ventricular arrhythmias
but there was a recorded episode of atrial fibrillation about 2 weeks prior that lasted 7 hours. Her
pacemaker settings were maintained. Her thyroid
hormones levels had improved, and no changes
were made to her treatment regimen. At her 4- and
6- month follow-up office visits, her ECGs showed
she was in atrial fibrillation and at her 7-month follow-up office visit, her ECG showed she was back
in normal sinus rhythm.
Transform Med | VVol 1, No 2. June, 2022 | https://doi.org/10.54299/tmed/arqe7136
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Figure 4: Rhythm

strip (A) and Electrocardiograph (B) post permanent
pacemaker showing normal sinus rhythm

A

B

DISCUSSION
Thyroid crisis is a fatal endocrine emergency that
presents with severe clinical manifestations of thyrotoxicosis1, and has a reported incidence of 0.57 –
0.75 cases per 100,000 person-years in the United
States in the past decade.7 Grave’s disease, an auto-immune disease of the thyroid gland, is the commonest cause of hyperthyroidism8. The production
of IgG autoantibodies that stimulate the thyroid
gland in Grave’s disease results in glandular hyperplasia and excess production of thyroid hormones
resulting in hyperthyroidism.8 The progression from
hyperthyroidism to the more concerning severe
thyrotoxicosis often occurs under the influence of
precipitating factors such as the discontinuation of
anti-thyroid medications, infection, stress and surgical procedures among others.1,2 Even though we do
not think that the Covid-19 infection was the cause
of the thyroid dysregulation in this patient given the
temporality of the occurrences, Covid-19 infection
© Tower Health

has, nevertheless, been associated with thyrotoxicosis through several mechanisms including systemic
immune activation.9–11 The inability to use standard
therapy in our case, is believed to have strongly contributed to the progression of the disease and subsequent clinical presentation. The manifestations
of severe thyrotoxicosis are often exaggerated and
multi-systemic with cardiovascular manifestations
being the most severe. The cardiac manifestations
include palpitations, angina pectoris, sinus tachycardia with bounding pulses, wide pulse pressure
and systolic ejection murmur among others.5 These
cardiac manifestations can progress to cardiovascular complications such as rhythm disturbances,
hypertension and sudden or high-output heart failure.5,6 Even in patients without a prior cardiac history, there is a danger to decompensate to these
life-threatening conditions.5,6 Heart failure due to a
tachycardia-mediated mechanism and diminished
myocardial contractile reserve develops in less than
a tenth of patients, with progression to dilated carTransform Med | Vol 1, No 2. June, 2022 | https://doi.org/10.54299/tmed/arqe7136
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diomyopathy with impaired left ventricular systolic
function in very rare instances.5,6 Systolic function is
often further compromised by sustained rhythm disturbances such as sinus tachycardia and atrial fibrillation.6 However, heart failure remains reversible
if hyperthyroidism is promptly treated. Although
our patient had prior diastolic dysfunction, her left
ventricular systolic function was preserved. Atrial
fibrillation remains one of the commonest cardiac
complications of hyperthyroidism, occurring in up
to 20% of patients, often spontaneously reverting
back to sinus rhythm with treatment of the hyperthyroidism. Other rhythm disturbances including atrial
flutter, supraventricular tachycardia, and ventricular
tachycardia are quite rare and could point towards
underlying heart disease.5 Sinus pauses and asystole
on the other hand are very uncommon and atypical
rhythm disturbances encountered in patients with severe thyrotoxicosis in contrast to patients with severe
hypothyroidism. We found only a single reported
case of asystole in the context of Grave’s disease-induced complete heart block from newly diagnosed
Grave’s disease.12 This was in a similar context of
recently diagnosed Grave’s disease and the patient
presented in a similar manner to our patient, with
recurrent syncope and asystole. Despite being temporarily paced, this patient subsequently required a
permanent dual-chamber pacemaker as our patient
did. This raises the possibility of thyroid hormone
acting directly on the sinus or atrio-ventricular (AV)
nodes.12 Interstitial inflammation of the cardiac conduction system including the AV node, bundle of
His and its branches demonstrated at autopsy13 may
contribute to the conduction disturbance. Other prior reported cases of sino-atrial and atrio-ventricular
conduction blocks with hyperthyroidism occurred in
settings of concurrent underlying co-morbidities or
conditions such as infection14, inflammation15, metabolic disorders such as hypercalcaemia16 or medication use or anti-thyroid medication discontinuation.17
The occurrence of these conduction blocks in such
situations is thought to be due to the underlying condition and often aggravated by the thyrotoxicosis. It
is unclear to what extent the use of propranolol in
this patient contributed to the sinus pauses, however, these pauses occurred following atrial fibrillation
rather than with observed or worsening bradycardia
which will be expected with beta adrenergic receptor blockers. Kramer et al, however, reported a case
of AV dissociation even with a small dose of propranolol in a hyperthyroid patient.17 Cardiac arrests
have been reported in the context of administration
of Landiolol administration in thyroid storm18 and
iodinated contrast medium induced thyroid storms.19
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Nevertheless, the occurrence of atrial fibrillation in
rapid succession with sinus pauses points towards
sinus node dysfunction as the etiology.
Atrial fibrillation and hyperthyroidism are considered as potentially reversible and treatable causes
of sinus node dysfunction on the current American
College of Cardiology/American Heart Association
(ACC/AHA) guidelines and are therefore not absolute indications for permanent pacemaker placement.20 Management in these cases is aimed at mitigating the offending condition.20 However, there are
currently no set guidelines with regards to managing
symptomatic sinus node dysfunction due to hyperthyroidism or thyrotoxicosis. Despite a report of
resolution of cardiac manifestations with anti-thyroid treatment,17 the management of sinus node dysfunction and atrio-ventricular conduction disorders
due to thyrotoxicosis, may require the placement
of a permanent pacemaker in addition to treatment
of the underlying hormonal disorder as observed in
this case and other prior reports.12,21 Updating guidelines to include the management options in such
rare situations could prove beneficial but remains
challenging. Until the mechanism of hyperthyroidism-induced bradycardia and sinus pauses, or atrioventricular block are better understood, the management of patients with such clinical presentations is
likely to rely on the clinical judgement and experience of the treating team and should be approached
on a case-to-case basis.
CONCLUSION
Asystole due to hyperthyroidism remains a rare
presentation of severe thyrotoxicosis and in even
rarer cases can occur in patients without associated
predisposing situations such as infection, inflammation or medication use as previously reported. The
mechanisms underlying this rhythm disturbance are
still not understood but appears it may require the
placement of a permanent pacemaker in additions to
treatment of the thyroid hormone disturbance using
standard hyperthyroid medications.
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